Literature DB >> 3007570

Elimination of nonspecific cytomegalovirus immunoglobulin M activities in the enzyme-linked immunosorbent assay by using anti-human immunoglobulin G.

L Joassin, M Reginster.   

Abstract

Direct enzyme-linked immunosorbent assay methods offer several advantages in assessing past or recent exposure to cytomegalovirus (CMV) infection, but there persist many pitfalls in the use of these methods for determining specific immunoglobulin M (IgM). The efficiency of absorption of sera by IgG-coated latex beads, aggregated human IgG, or Staphylococcus aureus, i.e., for removing nonspecific CMV IgM activities, was evaluated in comparison with the effect of an anti-human IgG hyperimmune serum. Large routine series comprising serum samples from patients of various clinical groups and healthy individuals were examined. The CMV IgM-positive samples were at first treated with latex or aggregated IgG, but these absorptions left too many CMV IgM-positive individuals. S. aureus increased the nonspecific activity of some sera and, in other cases, removed or impaired specific IgM activities. The anti-IgG treatment caused the disappearance of nonspecific CMV IgM activities that had resisted the other treatments, whereas specific activities remained intact. Utilizing this method, only 1.03% of the routine series patients remained CMV IgM positive by the enzyme-linked immunosorbent assay, a figure in good agreement with a mean probability of CMV antibody acquisition of 0.33% for the population living in Belgium. On the other hand, in a series of patients who were investigated for serological response to several viruses, eight individuals displayed multiple IgM activities after anti-IgG treatment. In these cases, most IgM activities were found in patients who had IgG toward the related antigen for a long time before transient IgM was detected. This result implies that to assess a diagnosis of primary infection, it is necessary to examine serial specimens for IgG acquisition accompanying specific IgM.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3007570      PMCID: PMC268697          DOI: 10.1128/jcm.23.3.576-581.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Cytomegalovirus mononucleosis in a healthy adult: association with hepatitis, secondary Epstein-Barr Virus antibody response and immunosuppression.

Authors:  P A Oill; M Fiala; J Schofferman; P E Byfield; L B Guze
Journal:  Am J Med       Date:  1977-03       Impact factor: 4.965

2.  Disseminated toxoplasmosis and cytomegalovirus infection complicating Hodgkin's disease.

Authors:  M A Luna; B Lichtiger
Journal:  Am J Clin Pathol       Date:  1971-04       Impact factor: 2.493

3.  A rountine diagnostic test for IgA and IgM antibodies to rubella virus: absorption of IgG with Staphylococcus aureus.

Authors:  J Ankerst; P Christensen; L Kjellén; G Kronvall
Journal:  J Infect Dis       Date:  1974-09       Impact factor: 5.226

4.  IgG, IgA, IgM, and IgD antiglobulins in juvenile rheumatoid arthritis.

Authors:  A Florin-Christensen; R M Arana; O G Morteo; M E Roux; O Hubscher
Journal:  Ann Rheum Dis       Date:  1974-01       Impact factor: 19.103

5.  The IgM antibody response in rubella during pregnancy.

Authors:  J Desmyter; M A South; W E Rawls
Journal:  J Med Microbiol       Date:  1971-02       Impact factor: 2.472

6.  Solid-phase radioimmunoassay of human immunoglobulin M and immunoglobulin G antibodies against herpes simplex virus type 1 capsid, envelope, and excreted antigens.

Authors:  K O Kalimo; R J Marttila; K Granfors; M K Viljanen
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

7.  Investigation of varicella-zoster virus-infected cell proteins that elicit antibody production during primary varicella using the immune transfer method.

Authors:  P E Palumbo; A M Arvin; C M Koropchak; A E Wittek
Journal:  J Gen Virol       Date:  1984-12       Impact factor: 3.891

8.  Alteration of lymphocyte subpopulations with cytomegalovirus infection in infancy.

Authors:  V Schauf; A J Strelkauskas; A Deveikis
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

Review 9.  Rheumatoid factor: its nature, specificity, and production in rheumatoid arthritis.

Authors:  P M Johnson; W P Faulk
Journal:  Clin Immunol Immunopathol       Date:  1976-11

10.  Cytomegalovirus antibody production in renal transplant patients.

Authors:  J Nagington
Journal:  J Hyg (Lond)       Date:  1971-12
View more
  5 in total

Review 1.  Immunoserology of infectious diseases.

Authors:  K James
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

2.  Immunoglobulin M to cytomegalovirus in primary and reactivation infections in renal transplant recipients.

Authors:  S Chou; D Y Kim; K M Scott; D L Sewell
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

3.  Diagnosis of toxoplasmosis by joint detection of immunoglobulin A and immunoglobulin M.

Authors:  M Arcavi; G Orfus; G Griemberg
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

4.  Improvement of serological diagnosis of neonatal cytomegalovirus infection by simultaneously testing for specific immunoglobulins E and M by antibody-capture enzyme-linked immunosorbent assay.

Authors:  S L Nielsen; E Rønholm; I Sørensen; P Jaeger; H K Andersen
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

5.  Detection by enzyme-linked immunosorbent assay of specific immunoglobulin G isotypes in primary and established cytomegalovirus infections.

Authors:  L Joassin; A Somze; M Reginster
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.